Thiotepa 65219-0029-20

Package NDC

65219-0029-20

Manufacturer: Fresenius Kabi Usa, Llc
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intracavitary, Intravenous, And Intravesical
Product Type: Human Prescription Drug
Marketing Start: April 11, 2022
Listing Expires: December 31, 2026
Application: ANDA214222

Need to source Thiotepa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Thiotepa	100 mg/1

Drug Class

Alkylating Drug [EPC]Alkylating Activity [MoA]Alkylating Drug [EPC]

Selected Package

65219-0029-20Selected

1 VIAL in 1 CARTON (65219-029-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL